Key Appointment Details
Jagsonpal Pharmaceuticals Limited appointed Mr. Anil Kumar Matai (DIN: 03122685) as an Additional Director in the category of Non-Executive Independent Director, effective June 25, 2026. The appointment is subject to approval of the shareholders.
Director Background
Mr. Matai brings more than three decades of leadership experience across the pharmaceutical and healthcare sectors. He has held senior leadership positions and has experience in strategic growth, business transformation and operational excellence.
Management Commentary
Manish Gupta, Managing Director, stated: "We are delighted to welcome Mr. Anil Kumar Matai to the Jagsonpal family. With his rich experience and deep understanding of the pharmaceutical and healthcare industry, Mr. Matai brings valuable will be instrumental as we continue to scale our business and pursue new growth opportunities."
Mr. Anil Kumar Matai stated: "I am delighted to join the Board of Jagsonpal Pharmaceuticals and look forward to collaborating with the Board and management team. I hope to leverage my experience and understanding of the pharmaceutical industry to contribute to the Company's growth, strengthen performance and create value for all stakeholders."
Company Background
Jagsonpal Pharmaceuticals Limited is a pharmaceutical company with over four decades in the Indian market. The company has a portfolio focusing on Gynaecology, Orthopaedics, Dermatology and Child-care segments. It has 20+ brands among Top 5 brands in their molecule category, pan-India presence, and a sales team of over 1000 professionals.